EvlaBio secures €21 million Seed Funding led by Kurma Partners as well as AdBio Partners, Boehringer Ingelheim, NRW.Venture (NRW.BANK) and HTGF .

Biotech Health services Manufacturing Pharma

Investments

02 July 2025

EvlaBio (company)

Biotech Health services Manufacturing Pharma

Total investments received (USD): 24.19m

Round value (USD): 24.19m

Round investors: Boehringer Ingelheim Venture Fund High-Tech Gründerfonds Kurma Life Science Partners NRW.BANK AdBio partners KHAN Technology Transfer Fund

Company: EvlaBio

Industry: Biotech Health services Manufacturing Pharma

Hardware Health services Manufacturing Software Services

Investments 01 November 2025

Biotech Health services Pharma

Investments 13 July 2025

Health services Manufacturing

Investments 06 February 2025